PDCD1 and neoplasm: However, the effective response to PD-1 blocking requires more tumor-infiltrating lymphocytes in the tumor microenvironment, which also indicates that pMMR tumors have limited efficacy owing to the lack of tumor-infiltrating lymphocytes (54) (Figure 1).